Transfusion Diagnosis for Donor Market
Transfusion Diagnosis for Donor Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Transfusion Diagnosis for Donor Market Size and Growth
The Transfusion Diagnosis for Donor market is experiencing significant growth, driven by increasing demand for blood components and advanced diagnostic technologies. The market size was estimated at approximately $1.5 billion in 2023, with projections of steady expansion due to innovations in screening processes and heightened awareness of transfusion safety. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Grifols
◍ F. Hoffmann-La Roche
◍ Abbott
◍ Bio-Rad Laboratories
◍ Werfen
◍ QuidelOrtho Corporation
◍ AliveDx Holdings Finance
◍ BAG Diagnostics GmbH
◍ Diasorin
◍ Prestige Diagnostics
◍ Atlas Medical GmbH
◍ Lorne Laboratories
The Transfusion Diagnosis for Donor Market features companies like Grifols, Roche, and Abbott, which develop blood screening assays and diagnostic reagents. These firms enhance market growth through innovation and expanded product portfolios. Notable 2022 sales include Grifols ($2.7 billion) and Abbott ($43 billion), driving advancements in transfusion diagnostics. Request Sample Report
Market Segmentation
By Application
Blood Banks
Blood Donation/Transfusion Centers
Others
Request Sample Report
By Product
Instruments
Kits and Reagents
Market Growth
Request Sample Report
$ X Billion USD
